Jump to Navigation Back to Graphic version

Syntopix

share price

71.00p


09:31:44 (15 min delay)


Home

Syntopix is a specialised research and development business, focusing on the discovery of topical antimicrobials for healthcare and pharmaceutical applications through the repositioning of known chemical entities that have a history of use in humans.

We seek to identify compounds and develop products that treat dermatological conditions, principally acne and topical staphylococcal infections, including those due to MRSA.

Our world class antimicrobial expertise is now also being successfully applied to other areas as we develop collaborative relationships with major healthcare companies.